Global Propranolol Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Propranolol Market Research Report 2024
Propranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
According to Mr Accuracy reports’s new survey, global Propranolol market is projected to reach US$ 477.8 million in 2034, increasing from US$ 386 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Propranolol market research.
Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.
Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent.
In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Propranolol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
Segment by Type
Oral
Injection
Arrhythmia
Hypertension
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Propranolol report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Propranolol market is projected to reach US$ 477.8 million in 2034, increasing from US$ 386 million in 2022, with the CAGR of 3.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Propranolol market research.
Global Propranolol key players include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, etc. Global top five manufacturers hold a share over 28%.
Europe is the largest market, with a share about 30%, followed by North America, and Asia-Pacific, both have a share about 44 percent.
In terms of product, Oral is the largest segment, with a share over 98%. And in terms of application, the largest application is Arrhythmia, followed by Hypertension, and Others.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Propranolol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
Segment by Type
Oral
Injection
Segment by Application
Arrhythmia
Hypertension
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Propranolol report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices